US Stock MarketDetailed Quotes

PSTV Plus Therapeutics

Watchlist

1.2800
+0.0200+1.59%

Close Nov 29 13:00 ET

1.3239
+0.0439+3.43%

Post 17:01 ET

7.55MMarket Cap-540P/E (TTM)

Plus Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Total revenue

Operating revenue

--0

Cost of revenue

Gross profit

Operating expense

16.86%3.8M

148.12%3.7M

-30.14%3.3M

-32.42%13.32M

-30.76%3.86M

-36.18%3.25M

-70.90%1.49M

20.28%4.72M

58.64%19.71M

43.20%5.57M

Selling and administrative expenses

19.97%2.4M

14.50%2.2M

-1.43%2.21M

-16.55%8.54M

-33.70%2.38M

-10.08%2M

-15.95%1.92M

4.86%2.25M

49.39%10.24M

75.56%3.59M

-General and administrative expense

19.97%2.4M

14.50%2.2M

-1.43%2.21M

-16.55%8.54M

-33.70%2.38M

-10.08%2M

-15.95%1.92M

4.86%2.25M

49.39%10.24M

75.56%3.59M

Research and development costs

14.64%2.86M

95.28%2.77M

-7.38%2.76M

-0.08%9.69M

30.68%2.79M

-15.35%2.49M

-49.84%1.42M

67.11%2.98M

74.02%9.7M

15.63%2.14M

Other operating expenses

-17.42%-1.46M

31.01%-1.28M

-231.42%-1.68M

-2,093.30%-4.91M

-769.54%-1.31M

-1,598.63%-1.24M

---1.85M

---506K

---224K

---151K

Operating profit

-16.86%-3.8M

-148.12%-3.7M

30.14%-3.3M

32.42%-13.32M

30.76%-3.86M

36.18%-3.25M

70.90%-1.49M

-20.28%-4.72M

-58.64%-19.71M

-43.20%-5.57M

Net non-operating interest income expense

-40.63%19K

-43,912.50%-3.51M

145.78%38K

100.89%5K

155.81%48K

125.60%32K

104.94%8K

56.54%-83K

38.23%-564K

60.55%-86K

Non-operating interest income

-32.77%80K

-44.17%67K

41.18%72K

172.11%400K

50.68%110K

147.92%119K

531.58%120K

628.57%51K

673.68%147K

1,116.67%73K

Non-operating interest expense

-29.89%61K

3,089.29%3.57M

-74.63%34K

-44.44%395K

-61.01%62K

-49.71%87K

-38.12%112K

-32.32%134K

-23.71%711K

-29.02%159K

Other net income (expense)

906K

4.26M

101.67%1K

Gain on sale of security

--906K

--4.26M

----

Other non- operating income (expenses)

----

--1K

----

Income before tax

10.72%-2.87M

-98.38%-2.94M

32.13%-3.26M

34.32%-13.32M

32.66%-3.81M

38.32%-3.22M

71.94%-1.48M

-16.74%-4.81M

-51.32%-20.28M

-36.17%-5.66M

Income tax

Net income

10.72%-2.87M

-98.38%-2.94M

32.13%-3.26M

34.32%-13.32M

32.66%-3.81M

38.32%-3.22M

71.94%-1.48M

-16.74%-4.81M

-51.32%-20.28M

-36.17%-5.66M

Net income continuous Operations

10.72%-2.87M

-98.38%-2.94M

32.13%-3.26M

34.32%-13.32M

32.66%-3.81M

38.32%-3.22M

71.94%-1.48M

-16.74%-4.81M

-51.32%-20.28M

-36.17%-5.66M

Minority interest income

Net income attributable to the parent company

10.72%-2.87M

-98.38%-2.94M

32.13%-3.26M

34.32%-13.32M

32.66%-3.81M

38.32%-3.22M

71.94%-1.48M

-16.74%-4.81M

-51.32%-20.28M

-36.17%-5.66M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

10.72%-2.87M

-98.38%-2.94M

32.13%-3.26M

34.32%-13.32M

32.66%-3.81M

38.32%-3.22M

71.94%-1.48M

-16.74%-4.81M

-51.32%-20.28M

-36.17%-5.66M

Basic earnings per share

63.00%-0.37

23.73%-0.45

63.77%-0.75

63.39%-4.24

70.34%-0.7

64.91%-1

83.43%-0.59

27.37%-2.07

30.45%-11.58

41.73%-2.36

Diluted earnings per share

63.00%-0.37

-20.34%-0.71

63.77%-0.75

63.39%-4.24

70.34%-0.7

64.91%-1

83.43%-0.59

27.37%-2.07

30.45%-11.58

41.73%-2.36

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Total revenue	0	0	0	0	0	0	0	0	0	0
Operating revenue	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	16.86%3.8M	148.12%3.7M	-30.14%3.3M	-32.42%13.32M	-30.76%3.86M	-36.18%3.25M	-70.90%1.49M	20.28%4.72M	58.64%19.71M	43.20%5.57M
Selling and administrative expenses	19.97%2.4M	14.50%2.2M	-1.43%2.21M	-16.55%8.54M	-33.70%2.38M	-10.08%2M	-15.95%1.92M	4.86%2.25M	49.39%10.24M	75.56%3.59M
-General and administrative expense	19.97%2.4M	14.50%2.2M	-1.43%2.21M	-16.55%8.54M	-33.70%2.38M	-10.08%2M	-15.95%1.92M	4.86%2.25M	49.39%10.24M	75.56%3.59M
Research and development costs	14.64%2.86M	95.28%2.77M	-7.38%2.76M	-0.08%9.69M	30.68%2.79M	-15.35%2.49M	-49.84%1.42M	67.11%2.98M	74.02%9.7M	15.63%2.14M
Other operating expenses	-17.42%-1.46M	31.01%-1.28M	-231.42%-1.68M	-2,093.30%-4.91M	-769.54%-1.31M	-1,598.63%-1.24M	---1.85M	---506K	---224K	---151K
Operating profit	-16.86%-3.8M	-148.12%-3.7M	30.14%-3.3M	32.42%-13.32M	30.76%-3.86M	36.18%-3.25M	70.90%-1.49M	-20.28%-4.72M	-58.64%-19.71M	-43.20%-5.57M
Net non-operating interest income expense	-40.63%19K	-43,912.50%-3.51M	145.78%38K	100.89%5K	155.81%48K	125.60%32K	104.94%8K	56.54%-83K	38.23%-564K	60.55%-86K
Non-operating interest income	-32.77%80K	-44.17%67K	41.18%72K	172.11%400K	50.68%110K	147.92%119K	531.58%120K	628.57%51K	673.68%147K	1,116.67%73K
Non-operating interest expense	-29.89%61K	3,089.29%3.57M	-74.63%34K	-44.44%395K	-61.01%62K	-49.71%87K	-38.12%112K	-32.32%134K	-23.71%711K	-29.02%159K
Other net income (expense)	906K	4.26M							101.67%1K	0
Gain on sale of security	--906K	--4.26M	----	----	----	----	----	----	----	----
Other non- operating income (expenses)	----	----	----	----	----	----	----	----	--1K	----
Income before tax	10.72%-2.87M	-98.38%-2.94M	32.13%-3.26M	34.32%-13.32M	32.66%-3.81M	38.32%-3.22M	71.94%-1.48M	-16.74%-4.81M	-51.32%-20.28M	-36.17%-5.66M
Income tax
Net income	10.72%-2.87M	-98.38%-2.94M	32.13%-3.26M	34.32%-13.32M	32.66%-3.81M	38.32%-3.22M	71.94%-1.48M	-16.74%-4.81M	-51.32%-20.28M	-36.17%-5.66M
Net income continuous Operations	10.72%-2.87M	-98.38%-2.94M	32.13%-3.26M	34.32%-13.32M	32.66%-3.81M	38.32%-3.22M	71.94%-1.48M	-16.74%-4.81M	-51.32%-20.28M	-36.17%-5.66M
Minority interest income
Net income attributable to the parent company	10.72%-2.87M	-98.38%-2.94M	32.13%-3.26M	34.32%-13.32M	32.66%-3.81M	38.32%-3.22M	71.94%-1.48M	-16.74%-4.81M	-51.32%-20.28M	-36.17%-5.66M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	10.72%-2.87M	-98.38%-2.94M	32.13%-3.26M	34.32%-13.32M	32.66%-3.81M	38.32%-3.22M	71.94%-1.48M	-16.74%-4.81M	-51.32%-20.28M	-36.17%-5.66M
Basic earnings per share	63.00%-0.37	23.73%-0.45	63.77%-0.75	63.39%-4.24	70.34%-0.7	64.91%-1	83.43%-0.59	27.37%-2.07	30.45%-11.58	41.73%-2.36
Diluted earnings per share	63.00%-0.37	-20.34%-0.71	63.77%-0.75	63.39%-4.24	70.34%-0.7	64.91%-1	83.43%-0.59	27.37%-2.07	30.45%-11.58	41.73%-2.36
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data